Regulation

Filter

Current filters:

None

Popular Filters

2310 to 2334 of 2736 results

GlaxoSmithKline files for EU and US approval for dabrafenib and trametinib

07-08-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) last week submitted regulatory filings in the European Union…

dabrafenibEuropeGlaxoSmithKlineNorth AmericaOncologyPharmaceuticalRegulationtrametinib

UK NICE draft guidance backs Servier's Procoralan for chronic heart failure

06-08-2012

The UK's drugs watchdog the National Institute for Health and Clinical Excellence (NICE), in draft guidance…

Cardio-vascularEuropePharmaceuticalPricingProcoralanRegulationServier

Zaltrap gains US approval for metastatic colorectal cancer

06-08-2012

The US Food and Drug Administration on Friday approved French drug major Sanofi (Euronext: SAN) and US…

North AmericaOncologyPharmaceuticalRegeneronRegulationSanofiZaltrap

Positive outlook for Vectura, as Seebri Breezhaler closer to EU approval

02-08-2012

UK-based inhalation product development company Vectura (LSE: VEC) is a step closer to European approval…

FinancialNovartisPharmaceuticalRegulationRespiratory and PulmonarySeebri BreezhalerVectura

European Medicines Agency phasing out follow-up measures for MAs

02-08-2012

The European Medicines Agency this week issued a statement reminding marketing-authorization holders…

BiotechnologyEuropePharmaceuticalRegulation

USA's PDUFA V begins with relatively modest changes to user fee rates

01-08-2012

In two Federal Register notices published on August 1, the US Food and Drug Administration announced…

BiotechnologyFinancialNorth AmericaPharmaceuticalRegulation

US FDA rejects Regeneron's Arcalyst sBLA for gout flare prevention

01-08-2012

US drugmaker Regeneron Pharmaceuticals (Nasdaq: REGN) says that the US Food and Drug Administration issued…

Anti-Arthritics/RheumaticsArcalystBiotechnologyNorth AmericaPharmaceuticalRegeneronRegulation

Positive new data for Pfizer's tofacitinib; possible regulatory delay

01-08-2012

Pfizer (NYSE:PFE), the world's largest drugmaker by sales, yesterday released positive top-line results…

Anti-Arthritics/RheumaticsNorth AmericaPfizerPharmaceuticalRegulationResearchtofacitinib

EMA increases interaction with Japanese regulators

30-07-2012

The European Medicines Agency has increased its level of interaction and cooperation with medicines regulatory…

Asia-PacificBiotechnologyEuropePharmaceuticalRare diseasesRegulation

EU approval for Eisai's epilepsy drug Fycompa and Vertex' Kalydeco

30-07-2012

Japanese drug major Eisai (TYO: 4523) says that the European Commission has approved for marketing its…

EisaiEuropeFycompaKalydecoNeurologicalPharmaceuticalRare diseasesRegulationVertex

Genentech gains FDA panel backing for Lucentis to treat DME

30-07-2012

US biotech firm Genentech, a subsidiary of Swiss drug major Roche (ROG: SIX), revealed last week that…

BiotechnologyGenentechLucentisNorth AmericaOphthalmicsPharmaceuticalRegulationRoche

US FDA clears Amarin's Vascepa, a competitor for Lovaza

30-07-2012

The US Food and Drug Administration has approved biotech firm Amarin's (Nasdaq: AMRN) Vascepa (icosapent…

AmarinBiotechnologyCardio-vascularGlaxoSmithKlineLovazaMergers & AcquisitionsNorth AmericaRegulationVascepa

FDA advisory panel backs approval of ThromboGenics' ocriplasmin for VMA

29-07-2012

Belgian biopharmaceutical firm ThromboGenics NV (Euronext Brussels: THR) says that the US Food and Drug…

AlconBiotechnologyNorth AmericaNovartisocriplasminOphthalmicsRegulationThromboGenics

US doctors, researchers and health officials want FDA action to deter mis-prescribing of opioid painkillers

26-07-2012

Labels on opioid pain medications should be revised to prevent overprescribing, a broad coalition of…

NeurologicalNorth AmericaPharmaceuticalRegulation

Global pharmaceutical approvals moderate as patent cliff peaks, says Fitch

26-07-2012

The Food and Drug Administration will approve fewer novel drugs in 2012 compared to 2011 while the industry…

BiotechnologyNorth AmericaPatentsPharmaceuticalRegulation

Boehringer and Lilly's combo diabetes drug Jentadueto gains EU approval

26-07-2012

Independent German drug major Boehringer Ingelheim and US partner Eli Lilly (NYSE: LLY) received Marketing…

Boehringer IngelheimDiabetesEli LillyEuropeJentaduetoPharmaceuticalRegulation

US FDA points to seizure risk with Acorda's MS drug Ampyra

25-07-2012

The US Food and Drug Administration has issued a warning about the risk of seizures in patients with…

Acorda TherapeuticsAmpyraNeurologicalNorth AmericaPharmaceuticalRegulation

2310 to 2334 of 2736 results

Back to top